Clinicians
Clinicians Home Consult Request Knowledge Base Education Catalog Centers Of Excellence
Individuals & Families
Guidance Knowledge Base Resources
Our Tools
Clozapine Dose Planner LAI Conversion Tool LAI Explorer
About Us
Contact

Search for:

∕
Knowledge Base (Clinicians)
∕
Depression

Tag: Depression

Knowledge Base (Clinicians)

129 result(s) found.

Do individuals with serious mental illness want their families involved in their care?
What are measures of organizational readiness and why use them?
Are there any reliable techniques to assess antipsychotic medication adherence?
What is patient-centered care?
What is Cognitive-Behavioral Therapy for Psychosis (CBTp)?
Using Antidepressants in Pregnancy
Employment of people with serious mental illness
What should be considered if someone with depression or bipolar disorder is not doing well with medications alone and wants to learn more about how to manage their condition? Any suggestions?
How can I or my colleagues get training in Life Goals?
What did we learn from the STAR*D study?
What is psychosis?
What side effects might be expected after starting an antidepressant medication for the first time?
How do I know if depression is severe?
How is Interpersonal Therapy different from Psychoanalysis for depression?
What is a capacity evaluation?
Is adjustment disorder a serious mental illness?
Does obstructive sleep apnea impact serious mental illnesses?
Is internet (online) based therapy effective for depression?
Are there any FDA smartphone apps approved for SMI?
How much exercise should people with SMI get per week?
What are smoking cessation tools for those with schizophrenia?
Are chatbots useful for serious mental illnesses?
Is substance abuse common in people with schizophrenia?
What is the best antidepressant to use in children?
Is peer support a valuable addition to services for people with SMI?
What does recovery mean for someone living with a serious mental health disorder?
What is Problem-Solving Therapy?
Is a person ever able to stop taking medications to treat their serious mental illness?
Practice Guidelines for the Psychiatric Evaluation of Adults, Third Edition
Depression in Adults: Screening
Medical Directors’ Recommendations on Trauma-informed Care for Persons with Serious Mental Illness
Why is it common for people with serious mental illness to need more than one medication?
Persistent Depression and Anxiety in the United States: Prevalence and Quality of Care
Can the medications used to treat serious mental illness (antipsychotics and antidepressants) be addicting?
How often should a full medical workup be done on a person with serious mental illness who is being treated with medications?
Fact Sheet: Trauma, PTSD and First Episode Psychosis
Addressing Trauma and PTSD in First Episode Psychosis Programs
Windows of Opportunity in Early Psychosis Care: Navigating Cultural Dilemmas
Management of physical health conditions in adults with severe mental disorders
Group Interpersonal Therapy (IPT) for Depression
Mood Stabilizers – Medication Fact Sheets
Antidepressants – Medication Fact Sheets
Second-Generation (atypical) Antipsychotics – Medication Fact Sheets
Self-administered screening tools
Is weight gain or obesity a side effect of antipsychotic medications, and what can be done?
What about ketamine for depression or suicidal ideation?
Perinatal Psychiatry
Serious Mental Illness and Treatment Prevalence
What are some guidelines to support those who have a serious mental illness, either diagnosed or suspected, in the prison system?
What is Illness Management and Recovery?
What are available practice guidelines for depression / major depressive disorder?
Is there a healthcare model that can treat medical problems, mental health conditions and substance use disorders at the same time and place?
What should I think about if a patient is moving from one county or state to another, is not competent to consent, on legal conservatorship, and requires treatment with Electroconvulsive Therapy (ECT)?
What metabolic monitoring is appropriate when patients are taking antipsychotic medication? Are there any labs or vital signs to monitor?
There is a known association between depression and pain but is there also a connection between bipolar disorder and pain?
Comparative Effectiveness Review Number 215: Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults
What metabolic monitoring is appropriate when patients are taking clozapine? Should we monitor weight, labs or vital signs?
What treatments are available for postpartum depression, or depression after childbirth?
What are the long-term effects of common antidepressant medications, such as SSRIs or SNRIs? Do they cause permanent changes?
What do we know about the effectiveness in anxiety, depression or insomnia of cranial electrotherapy stimulation (CES) devices such as transcranial alternating stimulator, pulsed current stimulator, Fisher Wallace device, or Alpha-Stim device?
Long-Term Effects of Evidence-Based Supported Employment on Earnings and on SSI and SSDI Participation Among Individuals With Psychiatric Disabilities
Fact Sheet: Career Development
Supported Employment: Keys to a Successful Facility
Barriers to Employment for those with Severe Mental Illnesses
There’s More to Young Adult Unemployment Than Mental Health: What Else to Look For
Blueprint for Building Inter-Agency Collaboration through Strategic Planning: Supporting the Employment of Youth & Young Adults with Serious Mental Health Conditions
Making it Work: Vocational Peer Mentors for Emerging Adults with Serious Mental Health Conditions (2014)
First and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update
Interventions for Adult Offenders With Serious Mental Illness
Nonpharmacological Versus Pharmacological Treatments for Adult Patients With Major Depressive Disorder
Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression: An Update of the 2007 Comparative Effectiveness Review
Treatment for Depression After Unsatisfactory Response to SSRIs in Adults and Adolescents
Comparative Effectiveness of Smoking Cessation Treatments for Patients With Depression: A Systematic Review and Meta-analysis of the Evidence
Thinking Healthy: A Manual for Psychological Management of Perinatal Depression
Training Projects/Weight Management and Well-being
Standardized Library of Depression Outcome Measures
Management Strategies To Reduce Psychiatric Readmissions
Transition Age Youth With Mental Health Challenges in the Juvenile Justice System (2013)
A Randomized Controlled Trial of Effects of Wellness Recovery Action Planningon Depression, Anxiety, and Recovery
Where can I find basic information about serious mental illness (SMI) to share with colleagues, individuals, and family members?
Wraparound for Older Youth and Young Adults
Free, Brief, and Validated: Standardized Instruments for Low-Resource Mental Health Settings
Understanding Neurobiology of Psychological Trauma: Tips for Working with Transition-age Youth
Supporting College Student Success Through Connections to Mentors and Campus Champions: A Strategy Brief For Campus-Based Mentors and Other Student Support Programs
Housing and Transition: Meeting the Needs of Young Adults with Mental Health Conditions
A Primer on the Psychiatric Rehabilitation Process
Screening and Assessment of Co-occurring Disorders in the Justice System
Reducing Criminal Recidivism for Justice-Involved Persons with Mental Illness: Risk/Needs/Responsivity and Cognitive-Behavioral Interventions
What is the best way to assess cognitive functioning in individuals with serious mental illness (SMI) without using a long battery of neurocognitive tests?
Community Provider Toolkit: Serving Veterans through Partnership
Would Transcranial Magnetic Stimulation (TMS) be appropriate for a person who has managed major depression for many years with medication, but who would prefer to stop taking medications?
First Episode Psychosis Resources: Focus on Effective Treatment Options
Providing Coordinated Specialty Care Services for First Episode Psychosis in Rural and Frontier Settings
Financing the Start-Up and Operation of First Episode Psychosis Programs
Key Substance Use and Mental Health Indicators in the United States: Results from the 2017 National Survey on Drug Use and Health
What is the standard of care for treating pregnant and parenting women with opioid use disorder and their infants?
What to Know About a New Diagnosis – Handout
When It Comes to SMI, Words Matter – Handout
Administering the Patient Health Questionnaires 2 and 9 (PHQ 2 and 9) in Integrated Care Settings
Epidemiology of First Episode Psychosis in Large Integrated Healthcare Systems
Issues in Accurate Diagnosis for Programs Serving Individuals with First Episode Psychosis
Issues and Considerations Associated with Measuring the Duration of Untreated Psychosis (DUP) in First Episode Psychosis Programs
Peer Involvement & Leadership in Early Intervention in Psychosis Services
Are there any concerns with regard to prescribing or using concomitant medications or substances during treatment with ketamine or transcranial magnetic stimulation (TMS)?
What can be done when a patient has depression that is treatment resistant (does not respond fully to antidepressant medication treatment)?
Antidepressants – Medication Fact Sheets (Spanish Version)
Mood Stabilizers – Medication Fact Sheets (Spanish Version)
Second-Generation (atypical) Antipsychotics – Medication Fact Sheets (Spanish Version)
What is collaborative care and how does it relate to depression treatment?
How effective are depression self-help apps for serious mental illness?
What is known about the causes of restless legs or akathisia?
What can I consider with regard to continuing treatment for patients with serious mental illness in the context of the coronavirus (COVID-19) pandemic?
For someone living with mental illness, could isolation and loneliness worsen their illness?
Can risperidone, paliperidone (Invega) or first generation antipsychotic medications cause elevated or high prolactin levels, and related side effects such as sexual dysfunction, gynecomastia or galactorrhea?
WEBINAR: Wellness Routines For Uncertain Times
WEBINAR: COVID-19 – How to Support Ourselves and Others Through Times of Fear and Isolation
WEBINAR: How to Increase Our Resiliency to Isolation and Loneliness During the COVID-19 Crisis
WEBINAR: Older Adults & Isolation During COVID-19
Depression in Female Veterans Returning from Deployment: The Role of Social Factors
Findings from a Feasibility Study of an Adapted Cognitive Behavioral Therapy Group Intervention to Reduce Depression among LGBTQ (Lesbian, Gay, Bisexual, Transgender, or Queer) Young People
Suicide Prevention, Part 1: Identifying and Predicting Risk, Vulnerable Populations, Public Perceptions, and Priority Settings
Fact Sheet: Major Depressive Disorder (English and Spanish)
Is ECT an effective treatment for SMI?
Perinatal Psychiatry, 2021: Improving Access to Perinatal Mental Health Care
Talking to Individuals and Families About Transcranial Magnetic Stimulation (TMS)
Talking to Individuals and Families About Electroconvulsive Therapy (ECT)
What is Stanford neuromodulation therapy (SNT) and how effective is it for treatment-resistant depression?
How effective and safe are mental health apps for my clients?
How do I prescribe lithium?

Administered by

About SMI Adviser

Mission Statement

Our mission is to advance the use of a person-centered approach to care that ensures people who have SMI find the treatment and support they need.

For clinicians, we offer access to education, data, and consultations so you can make evidence-based treatment decisions.

For patients, families, friends, people who have questions, or people who care for someone with SMI, we offer access to resources and answers from a national network of experts.

Grant Statement

Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.

Terms & Privacy
Copyright

Sitemap

Clinicians
Individuals & Families
About
Contact

SMI Adviser is committed to ensuring accessibility of its website to people with disabilities. If you have trouble accessing any of the website's resources, please call us at 202-559-3900 for assistance.

Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.

© 2025 American Psychiatric Association. All rights reserved.